Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Amgen VP Makes Case for Longer Exclusivity Period in Follow-on Biologics Legislation

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- For the past two years, much of the debate surrounding the various follow-on biologics bills that have been introduced in Congress has centered on the exclusivity periods provided by each bill. So far, three follow-on biologics bills have been introduced in the 111th Congress: H.R. 1427 and its companion bill, S. 726, which would provide up to 5.5 years of exclusivity, and H.R. 1548, which would provide up to 14.5 years of exclusivity. At last month's Biotechnology Industry Organization (BIO) Intellectual Property Counsels' Committee (IPCC) conference, Stuart Watt, Vice President and Law & Intellectual Property Officer...

Full post as published by Patent Docs on April 23, 2009 (boomark / email).